Newsroom
Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
Originally published on 360DX.com by Greg Cima, Mar23, 2023. By Greg Cima NEW YORK – Backed by a mix of governmental contracts and VC funding, Irish startup Altratech is laying out a bold vision that its home-use microfluidic tests could Read More
Meet us at our Tri-Con San Diego booth 305 on Mar 6-8, and hear CEO Tara Dalton present our technology at the home-diagnostics session Tues 7th
Hear from our CEO Tara Dalton as she presents our technology in the home diagnostics session on Tuesday 7th of March.Title of session: 'At-Home Next-Generation Molecular Detection with All-Synthetic PNA and CMOS'
EIC ‘Best-Pitch, E-Health’ Award for Altratech
Altratech's CTO, Tim Cummins, wins EIC 'Best-Pitch, E-Health' Award at EIC-CUF Healthcare Investor Day. Pictured with Cornelius Schmaltz, Ph.D, Head of Unit EIC Accelerator, EISMEA.
Altratech contracted by BARDA for novel PNA Saliva SARS-CoV-2 project
This project has been funded in whole or in part with Federal funds from the US Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00067
Altratech presents at World Point of Care and At Home Diagnostics Summit 2022
Dr Tara Dalton will be presenting Altratech's technology and assay at the World Home Diagnostics Summit in San Diego on November 30th.
Altratech presents at NextGenDx 2022
At NextGenDx conference (Aug 2022), Altratech presented "Enabling Point-of-Care Diagnostics"
